Piper Sandler analyst Jessica Tassan believes performance guarantee achievement and PlushCare could provide upside to Accolade’s $410M revenue guidance for fiscal 2024. The firm thinks concerns around the company’s Core Navigation growth are unfounded and keeps an Overweight rating on the shares with a $16.50 price target. It would buy the stock into Accolade’s May 8 investor day for visibility into fiscal 2025 revenue and a potential upward revision to the company’s 2025 adjusted EBITDA outlook.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ACCD:
- Accolade price target raised to $16 from $14 at DA Davidson
- Accolade price target raised to $18 from $16 at Guggenheim
- Accolade price target raised to $14 from $11 at Morgan Stanley
- Accolade price target raised to $18 from $14 at Canaccord
- Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2023